<?xml version="1.0" encoding="UTF-8"?>
<p>As life expectancy is rising and chronical pathologies along with it, the prevalence of accompanying pain is expected to increase yearly, with higher prevalence in elderly patients, where the treatment is also more sensitive [
 <xref rid="B6" ref-type="bibr">6</xref>, 
 <xref rid="B7" ref-type="bibr">7</xref>]. Considering the above, new therapeutic agents with increased efficacy, less side effects, and lower costs and leading to an improved quality of life [
 <xref rid="B8" ref-type="bibr">8</xref>â€“
 <xref rid="B11" ref-type="bibr">11</xref>] should become one of the primary objectives in modern medical research, together with constant monitoring [
 <xref rid="B12" ref-type="bibr">12</xref>] of the previous mentioned aspects.
</p>
